Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dot-immunobinding assay with a monoclonal antibody for detection of group B meningococcal antigen.

× No keyword cloud information.

11 in total

1. Latex agglutination in diagnosis of bacterial infections, with special reference to patients with meningitis and septicemia.

Authors: J Kaldor; R Asznowicz; D G Buist
Journal: Am J Clin Pathol Date: 1977-08 Impact factor: 2.493

2. Immunoenzymatic analysis by monoclonal antibodies of bacterial lipopolysaccharides after transfer to nitrocellulose.

Authors: H Sidberry; B Kaufman; D C Wright; J Sadoff
Journal: J Immunol Methods Date: 1985-02-11 Impact factor: 2.303

3. Immunologic response of man to group B meningococcal polysaccharide vaccines.

Authors: F A Wyle; M S Artenstein; B L Brandt; E C Tramont; D L Kasper; P L Altieri; S L Berman; J P Lowenthal
Journal: J Infect Dis Date: 1972-11 Impact factor: 5.226

4. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

Authors: J Finne; M Leinonen; P H Mäkelä
Journal: Lancet Date: 1983-08-13 Impact factor: 79.321

Review 5. Monoclonal antibodies against microorganisms.

Authors: R A Polin
Journal: Eur J Clin Microbiol Date: 1984-10 Impact factor: 3.267

6. A dot-immunobinding assay for monoclonal and other antibodies.

Authors: R Hawkes; E Niday; J Gordon
Journal: Anal Biochem Date: 1982-01-01 Impact factor: 3.365

7. Failure of diagnosing group B meningococcal meningitis by immunoelectroosmophoresis.

Authors: J P Ghanassia; A Slim; E Bergogne-Berezin; J Modai
Journal: Scand J Infect Dis Date: 1977

8. Investigation of enzyme immunoassay time courses: development of rapid assay systems.

Authors: R H Yolken; F J Leister
Journal: J Clin Microbiol Date: 1981-04 Impact factor: 5.948

9. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli.

Authors: A S Cross; W Zollinger; R Mandrell; P Gemski; J Sadoff
Journal: J Infect Dis Date: 1983-01 Impact factor: 5.226

10. NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci.

Authors: M Frosch; I Görgen; G J Boulnois; K N Timmis; D Bitter-Suermann
Journal: Proc Natl Acad Sci U S A Date: 1985-02 Impact factor: 11.205

1 in total

Review 1. Immunoblotting and dot blotting.

Authors: D I Stott
Journal: J Immunol Methods Date: 1989-05-12 Impact factor: 2.303

1 in total